INSYS Therapeutics Inc (NASDAQ:INSY)

7.79
Delayed Data
As of Feb 16
 -0.31 / -3.83%
Today’s Change
4.10
Today|||52-Week Range
15.02
-19.02%
Year-to-Date
The Hottest Investing Plays in the Booming Weed Industry for 2018
Feb 15 / TheStreet.com - Paid Partner Content
Opioid Litigants Get Boost From Senate Report
Feb 13 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close8.10
Today’s open8.28
Day’s range7.76 - 8.28
Volume636,945
Average volume (3 months)1,431,492
Market cap$571.1M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-87.01%
Earnings growth (this year)-208.77%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)-26.76%
P/E ratioNM
Price/Sales2.82
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-0.50-3.56%
SGYPSynergy Pharmaceutic...-0.08-3.79%
LCILannett Company Inc-0.65-3.67%
VSARVersartis Inc0.000.00%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$242.3M
Annual profit (last year)$7.6M
Net profit margin3.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Saeed Motahari
Chief Financial Officer
Andrew G. Long
Corporate headquarters
Chandler, Arizona

Forecasts